QLT INC | 6,007 Euro | -0,002 -0,03 % | |
| WKN: 877927 ISIN: CA7469271026 Ticker-Symbol: QLT | Frankfurt | 21.05.13 | 08:06 Uhr |
Branche PharmaAktienmarkt NASDAQ Biotech |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 07.05. | QLT Narrows Loss | 2 | Zacks | |
| 02.05. | QLT Inc: QLT loses $6.42-million (U.S.) in Q1 | - | Stockwatch | |
| 02.05. | QLT INC/BC - 8-K, Current Report | - | SEC Filings | |
| 30.04. | QLT INC/BC - 10-K/A, Annual Report | - | SEC Filings | |
| 23.04. | The Zacks Analyst Blog Highlights: Elan, Biogen Idec, WuXi PharmaTech, QLT and Reynolds American | 55 | PR Newswire | |
| CHICAGO, April 23, 2013 /PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and... Mehr lesen zu: The Zacks Analyst Blog Highlights: Elan, Biogen Idec, WuXi PharmaTech, QLT and Reynolds American | ||||
| 15.04. | QLT splashing US$200 million in cash | 4 | Stockhouse | |
| 15.04. | UPDATE: QLT Proposes $200M Special Cash Distribution to Shareholders | 1 | Benzinga.com | |
| 15.04. | QLT INC/BC - 8-K, Other Events Financial Statements and Exhibits | - | SEC Filings | |
| 15.04. | QLT, Inc. (QLTI) Board Approves $200M Special Cash Distribution, or $3.95/Sh | - | StreetInsider.com | |
| 05.04. | QLT Sells PPDS Technology | 1 | Zacks | |
| 04.04. | The Zacks Analyst Blog Highlights:Elan, Biogen Idec, Cytokinetics, QLT and Medtronic | 102 | PR Newswire | |
| CHICAGO, April 4, 2013 /PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting... Mehr lesen zu: The Zacks Analyst Blog Highlights:Elan, Biogen Idec, Cytokinetics, QLT and Medtronic | ||||
| 28.03. | QLT: The Winning Streak Continues | 1 | SmarTrend | |
| 15.03. | Zacks Bull and Bear of the Day Highlights: Popular, Garmin, Mylan, Lannett and QLT | 90 | PR Newswire | |
| CHICAGO, March 15, 2013 /PRNewswire/ --Zacks Equity Research highlights Popular Inc (Nasdaq:BPOP) as the Bull of the Day and Garmin (Nasdaq:GRMN) as the Bear of the Day. In addition... Mehr lesen zu: Zacks Bull and Bear of the Day Highlights: Popular, Garmin, Mylan, Lannett and QLT | ||||
| 26.02. | QLT's Loss Narrows in 4Q | 1 | Zacks | |
| 24.12. | QLT Enters Option Agreement with Mati Therapeutics for Potential Sale of Punctal Plug Delivery System | 1 | Benzinga.com | |
| 24.12. | QLT Inc. Announces Option Deal for Potential Sale of Punctal Plug Delivery Systems | - | Benzinga.com | |
| 24.12. | QLT Inc. QLTI) Grants Purchase Option for PPDS Unit | - | StreetInsider.com | |
| 06.12. | QLT Announces 42% Reduction in Workforce | - | Benzinga.com | |
| 06.12. | QLT Inc. (QLTI) to Cut Workforce by 42% | - | StreetInsider.com | |
| 24.09. | Valeant Pharmaceuticals Acquires Visudyne From QLT | 61 | PR Newswire | |
| MONTREAL, Sept. 24, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that it has acquired Visudyne®, used to treat abnormal growth of leaky... Mehr lesen zu: Valeant Pharmaceuticals Acquires Visudyne From QLT | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| GILEAD SCIENCES | 43,641 | +0,49 % | Maximieren Sie Ihren Ertrag in nur 30 Minuten! (Freenet +370% / Technotrans +100% / Gilead +120% ...) |
| NOVARTIS | 57,86 | -0,10 % | Gericht prüft Klage von Pharmakonzern Novartis gegen Bewertung |
| ASTEX PHARMACEUTICALS | 4,171 | -2,23 % | Astex Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 03:30 PM |
| NPS PHARMACEUTICALS | 10,739 | -1,50 % | NPS Pharmaceuticals Bullish Moving Average Crossover Alert |
| ALNYLAM PHARMACEUTICALS | 21,161 | -0,06 % | Alnylam Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria |
